| PDB code | Main view | Title | | 1ao6 |  | Crystal structure of human serum albumin |
| 1bj5 |  | Human serum albumin complexed with myristic acid |
| 1bke |  | Human serum albumin in a complex with myristic acid and tri- iodobenzoic acid |
| 1bm0 |  | Crystal structure of human serum albumin |
| 1e78 |  | Crystal structure of human serum albumin |
| 1e7a |  | Crystal structure of human serum albumin complexed with the general anesthetic propofol |
| 1e7b |  | Crystal structure of human serum albumin complexed with the general anesthetic halothane |
| 1e7c |  | Human serum albumin complexed with myristic acid and the general anesthetic halothane |
| 1e7e |  | Human serum albumin complexed with decanoic acid (capric acid) |
| 1e7f |  | Human serum albumin complexed with dodecanoic acid (lauric acid) |
| 1e7g |  | Human serum albumin complexed with tetradecanoic acid (myristic acid) human serum albumin complexed with myristic acid |
| 1e7h |  | Human serum albumin complexed with hexadecanoic acid (palmitic acid) |
| 1e7i |  | Human serum albumin complexed with octadecanoic acid (stearic acid) |
| 1gni |  | Human serum albumin complexed with cis-9-octadecenoic acid (oleic acid) |
| 1gnj |  | Human serum albumin complexed with cis-5,8,11,14-eicosatetraenoic acid (arachidonic acid) |
| 1h9z |  | Human serum albumin complexed with myristic acid and the r-(+) enantiomer of warfarin |
| 1ha2 |  | Human serum albumin complexed with myristic acid and the s- (-) enantiomer of warfarin |
| 1hk1 |  | Human serum albumin complexed with thyroxine (3,3',5,5'-tetraiodo-l-thyronine) |
| 1hk2 |  | Human serum albumin mutant r218h complexed with thyroxine (3,3',5,5'-tetraiodo-l-thyronine) |
| 1hk3 |  | Human serum albumin mutant r218p complexed with thyroxine (3,3',5,5'-tetraiodo-l-thyronine) |
| 1hk4 |  | Human serum albumin complexed with thyroxine (3,3',5,5'-tetraiodo-l-thyronine) and myristic acid (tetradecanoic acid) |
| 1hk5 |  | Human serum albumin mutant r218h complexed with thyroxine (3,3',5,5'-tetraiodo-l-thyronine) and myristic acid (tetradecanoic acid) |
| 1j78 |  | Crystallographic analysis of the human vitamin d binding protein |
| 1j7e |  | A structural basis for the unique binding features of the human vitamin d-binding protein |
| 1kw2 |  | Crystal structure of uncomplexed vitamin d-binding protein |
| 1kxp |  | Crystal structure of human vitamin d-binding protein in complex with skeletal actin |
| 1lot |  | Crystal structure of the complex of actin with vitamin d- binding protein |
| 1ma9 |  | Crystal structure of the complex of human vitamin d binding protein and rabbit muscle actin |
| 1n5u |  | X-ray study of human serum albumin complexed with heme |
| 1o9x |  | Human serum albumin complexed with tetradecanoic acid (myristic acid) and hemin |
| 1tf0 |  | Crystal structure of the ga module complexed with human serum albumin |
| 1uor |  | X-ray study of recombinant human serum albumin. phases determined by molecular replacement method, using low resolution structure model of tetragonal form of human serum albumin |
| 1ysx |  | Solution structure of domain 3 from human serum albumin complexed to an anti-apoptotic ligand directed against bcl- xl and bcl-2 |
| 2bx8 |  | Human serum albumin complexed with azapropazone |
| 2bxa |  | Human serum albumin complexed with 3-carboxy-4-methyl-5- propyl-2-furanpropanoic acid (cmpf) |
| 2bxb |  | Human serum albumin complexed with oxyphenbutazone |
| 2bxc |  | Human serum albumin complexed with phenylbutazone |
| 2bxd |  | Human serum albumin complexed with warfarin |
| 2bxe |  | Human serum albumin complexed with diflunisal |
| 2bxf |  | Human serum albumin complexed with diazepam |
| 2bxg |  | Human serum albumin complexed with ibuprofen |
| 2bxh |  | Human serum albumin complexed with indoxyl sulfate |
| 2bxi |  | Human serum albumin complexed with myristate and azapropazone |
| 2bxk |  | Human serum albumin complexed with myristate, azapropazone and indomethacin |
| 2bxl |  | Human serum albumin complexed with myristate and 3,5- diiodosalicylic acid |
| 2bxm |  | Human serum albumin complexed with myristate and indomethacin |
| 2bxn |  | Human serum albumin complexed with myristate and iodipamide |
| 2bxo |  | Human serum albumin complexed with myristate and oxyphenbutazone |
| 2bxp |  | Human serum albumin complexed with myristate and phenylbutazone |
| 2bxq |  | Human serum albumin complexed with myristate, phenylbutazone and indomethacin |
| 2esg |  | Solution structure of the complex between immunoglobulin iga1 and human serum albumin |
| 2i2z |  | Human serum albumin complexed with myristate and aspirin |
| 2i30 |  | Human serum albumin complexed with myristate and salicylic acid |
| 2vdb |  | Structure of human serum albumin with s-naproxen and the ga module |
| 2vue |  | Human serum albumin complexed with 4z,15e-bilirubin-ix- alpha |
| 2vuf |  | Human serum albumin complexed with fusidic acid |
| 3b9l |  | Human serum albumin complexed with myristate and azt |
| 3b9m |  | Human serum albumin complexed with myristate, 3'-azido-3'- deoxythymidine (azt) and salicylic acid |
| 3cx9 |  | Crystal structure of human serum albumin complexed with myristic acid and lysophosphatidylethanolamine |